|
ISPECIMEN Inc. (ISPC) DCF Valoración
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
iSpecimen Inc. (ISPC) Bundle
¡Streamline ISPECIMEN Inc. (ISPC) Valoración con nuestra calculadora DCF personalizable! Utilizando datos financieros de ISpecimen reales y parámetros de pronóstico ajustable, puede explorar varios escenarios y determinar el valor razonable de ISpecimen en solo minutos.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.3 | 8.2 | 11.1 | 10.4 | 9.9 | 12.8 | 16.5 | 21.2 | 27.3 | 35.2 |
Revenue Growth, % | 0 | 90.4 | 36.06 | -6.58 | -4.56 | 28.83 | 28.83 | 28.83 | 28.83 | 28.83 |
EBITDA | -2.5 | -1.7 | -5.9 | -8.8 | -9.1 | -7.9 | -10.2 | -13.1 | -16.9 | -21.8 |
EBITDA, % | -58.73 | -21.21 | -52.58 | -84.61 | -91.7 | -61.77 | -61.77 | -61.77 | -61.77 | -61.77 |
Depreciation | .6 | .8 | 1.0 | 1.2 | 2.1 | 1.7 | 2.2 | 2.8 | 3.6 | 4.7 |
Depreciation, % | 14.77 | 10.02 | 9.02 | 11.59 | 20.81 | 13.24 | 13.24 | 13.24 | 13.24 | 13.24 |
EBIT | -3.2 | -2.6 | -6.9 | -10.0 | -11.2 | -9.3 | -11.9 | -15.4 | -19.8 | -25.5 |
EBIT, % | -73.51 | -31.22 | -61.6 | -96.2 | -112.5 | -72.51 | -72.51 | -72.51 | -72.51 | -72.51 |
Total Cash | .1 | .7 | 27.7 | 15.3 | 5.0 | 6.7 | 8.6 | 11.0 | 14.2 | 18.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1.4 | 2.4 | 4.9 | 3.9 | 2.9 | 4.4 | 5.7 | 7.3 | 9.4 | 12.2 |
Account Receivables, % | 32.4 | 28.82 | 43.85 | 37.74 | 29.62 | 34.48 | 34.48 | 34.48 | 34.48 | 34.48 |
Inventories | .1 | .0 | -3.0 | .0 | .0 | -.7 | -.8 | -1.1 | -1.4 | -1.8 |
Inventories, % | 1.28 | 0 | -26.96 | 0.000009613256 | 0 | -5.14 | -5.14 | -5.14 | -5.14 | -5.14 |
Accounts Payable | .7 | 1.8 | .8 | 2.5 | 3.9 | 2.8 | 3.6 | 4.7 | 6.0 | 7.7 |
Accounts Payable, % | 17.16 | 21.9 | 7.48 | 23.64 | 39.54 | 21.94 | 21.94 | 21.94 | 21.94 | 21.94 |
Capital Expenditure | -1.5 | -1.1 | -1.0 | -3.2 | -4.7 | -3.5 | -4.5 | -5.8 | -7.4 | -9.6 |
Capital Expenditure, % | -34.32 | -13.47 | -9.32 | -30.68 | -47.79 | -27.12 | -27.12 | -27.12 | -27.12 | -27.12 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -3.1 | -3.7 | -7.7 | -8.8 | -11.2 | -9.0 | -11.6 | -14.9 | -19.2 | -24.8 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -4.6 | -3.9 | -8.2 | -11.2 | -11.4 | -12.7 | -14.1 | -18.2 | -23.5 | -30.3 |
WACC, % | 25.6 | 26.1 | 26.1 | 24.25 | 26.1 | 25.63 | 25.63 | 25.63 | 25.63 | 25.63 |
PV UFCF | ||||||||||
SUM PV UFCF | -47.4 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -31 | |||||||||
Terminal Value | -131 | |||||||||
Present Terminal Value | -42 | |||||||||
Enterprise Value | -89 | |||||||||
Net Debt | -2 | |||||||||
Equity Value | -87 | |||||||||
Diluted Shares Outstanding, MM | 0 | |||||||||
Equity Value Per Share | -192.31 |
What You Will Get
- Comprehensive ISPC Financials: Access to both historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess iSpecimen's future performance.
- User-Friendly Design: Designed for industry professionals while remaining approachable for newcomers.
Key Features
- Customizable Data Inputs: Adjust essential parameters such as specimen availability, market demand, and pricing strategies.
- Instant Market Analysis: Provides real-time insights into market trends and competitive positioning.
- High-Precision Analytics: Leverages iSpecimen’s extensive data for accurate market forecasts and strategic planning.
- Effortless Scenario Simulation: Easily explore various market conditions and analyze potential impacts.
- Efficiency Booster: Streamlines the process of data management and analysis, saving valuable time.
How It Works
- Step 1: Download the prebuilt Excel template with iSpecimen Inc.'s (ISPC) data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the essential metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including iSpecimen Inc.'s (ISPC) intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose iSpecimen Inc. (ISPC)?
- Innovative Solutions: Provides a comprehensive platform for specimen sourcing and management.
- Flexible Options: Tailor your specimen requests to meet specific research needs and requirements.
- In-Depth Analytics: Access detailed insights into specimen availability and historical data trends.
- Robust Database: A vast collection of specimens ensures a wide range of options for researchers.
- Expert Support: Backed by a team of professionals dedicated to assisting clients in their research endeavors.
Who Should Use This Product?
- Investors: Accurately assess iSpecimen Inc.'s (ISPC) market potential before making investment choices.
- CFOs: Utilize a professional-grade DCF model for precise financial reporting and analysis.
- Consultants: Effortlessly customize the template for client valuation reports.
- Entrepreneurs: Discover financial modeling techniques employed by leading biotech firms.
- Educators: Implement it as a teaching resource to illustrate valuation methods.
What the Template Contains
- Historical Data: Includes iSpecimen Inc.'s (ISPC) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate iSpecimen Inc.'s (ISPC) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of iSpecimen Inc.'s (ISPC) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.